Table 2.

Comparison of Baseline Characteristics of 7 Patients who died or underwent Liver Transplant for HBV related Liver Disease to the 35 Patients who did not.

Characteristic	Survival (n=35)	Death or Liver Tx (n=7)	p value
Age (years)*	47 (14–71)	50 (34–58)	0.15
Male Sex	31 (89%)	5 (71%)	0.26
Race: White or Caucasian	19	3
Black or African-American	2	0	0.77
Asian-American	14	4
ALT (U/L)*	107 (28–524)	91 (64–156)	0.35
AST (U/L)*	67 (25–331)	71 (52–145)	0.82
Bilirubin (mg/dL)*	0.6 (0.3–3.0)	0.8 (0.3–1.8)	0.45
Albumin (g/dL)*	4.1 (1.7–4.7)	3.9 (2.7–4.4)	0.06
Prothrombin time (sec)*	13.1 (11.3–15.0)	13.1 (12.2–14.3)	0.51
Platelet count (per µL)*	191 (96–346)	135 (33–169)	0.001
APRI*	1.0 (0.2–6.2)	1.5 (1.1–12.9)	0.13
HBV DNA (log IU/mL)*	8.3 (5.4–10.4)	7.7 (6.4–9.7)	0.95
HBsAg concentration (log IU/mL)*	3.4 (1.9–5.3)	3.0 (2.1–5.1)	0.48
Genotype: A	18	3
C	11	4	0.59
D	5	0
E	1	0
HAI score (0–18)*	11 (3–17)	13 (7–16)	0.31
Ishak score (0–6)*	4 (0–6)	5 (4–6)	0.004
Cirrhosis	7 (20%)	6** (86%)	0.002
HBeAg positivity	18 (51%)	4 (57%)	1.00

^*Median (range).

^**Imputed for one case.